Pulse Biosciences, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $5.56M.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $465.00K, a 32.10% increase year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was -$7.00K.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $241.00K, a 32.42% increase year-over-year.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $586.00K, a 22.59% increase from fiscal 2024.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $478.00K, a 21.01% increase from fiscal 2023.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $395.00K, a 18.72% decline from fiscal 2022.
- Pulse Biosciences, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $486.00K, a 40.00% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $5.56M 10-Q · filed 2026-08-06 | $6.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $465.00K 10-Q · filed 2026-08-06 | $699.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $586.00K 10-K · filed 2026-02-19 |
| 2025-09-30 | $241.00K 10-Q · filed 2025-11-05 | $593.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $534.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $352.00K 10-Q · filed 2026-08-06 | $534.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $478.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $182.00K 10-Q · filed 2025-11-05 | $478.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $399.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $296.00K 10-Q · filed 2025-05-08 | $400.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $395.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $103.00K 10-Q · filed 2024-10-30 | $395.00K derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $405.00K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $291.00K 10-Q · filed 2024-05-07 | $404.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $486.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $113.00K 10-Q · filed 2023-11-13 | $485.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $761.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $372.00K 10-Q · filed 2023-05-11 | $3.23M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $810.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $389.00K 10-Q · filed 2022-11-10 | $3.29M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $2.47M 10-Q · filed 2021-08-09 | $3.13M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $430.00K 10-Q · filed 2022-05-11 | $665.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $490.00K 10-K · filed 2023-03-31 |
| 2020-09-30 | $235.00K 10-Q · filed 2021-11-15 | $490.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $456.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $255.00K 10-Q · filed 2021-05-10 | $456.00K derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $423.00K 10-K · filed 2022-03-31 |
| 2019-09-30 | $201.00K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2019-03-31 | $222.00K 10-Q · filed 2020-05-11 | |
| 2018-09-30 | $139.00K 10-Q · filed 2019-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |